Trial intelligence / Profile preview

ZG005 + gilteritinib in relapsed or refractory lymphoma (phase I/II)

ChiCTR2500114728Phase 2Recruiting

Sponsor

First Affiliated Hospital, Zhejiang University School of Medicine

Start

Dec 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1